Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | São Paulo medical journal (Online) |
Texto Completo: | https://periodicosapm.emnuvens.com.br/spmj/article/view/1843 |
Resumo: | CONTEXT AND OBJECTIVE: Cross-linked N-telopeptides of type I collagen (NTx) increase in concentration in situations in which bone resorption is increased, such as osteoporosis and bone metastasis (BM). We aimed to evaluate the serum concentrations of NTx in a sample of patients with several types of solid tumors. DESIGN AND SETTING: Cross-sectional analytical study with a control group in a tertiary public hospital. METHODS: We performed the quantitative enzyme-linked immunosorbent assay (ELISA) on serum NTx levels in 19 subjects without a history of cancer and 62 patients with various solid tumors who had been referred for a bone scan. Three experienced analysts read all bone scans. RESULTS: The serum NTx levels in patients with cancer and BM, with cancer but without BM and without cancer were 46.77 ± 2.58, 32.85 ± 2.05 and 22.32 ± 2.90 respectively (P < 0.0001). We did not find any significant correlations of serum NTx with age, gender, history of bone pain, tumor type and bone alkaline phosphatase levels. We found a significant correlation between serum NTx and alkaline phosphatase levels (R2 = 0.08; P = 0.022). CONCLUSIONS: Serum NTx levels are significantly higher in patients with solid tumors and bone metastases than they are in patients without bone metastases and in normal controls. |
id |
APM-1_f8f50acf1a8fcd6d4d8fc62cc1e51367 |
---|---|
oai_identifier_str |
oai:ojs.diagnosticoetratamento.emnuvens.com.br:article/1843 |
network_acronym_str |
APM-1 |
network_name_str |
São Paulo medical journal (Online) |
repository_id_str |
|
spelling |
Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumorsDosagem sérica do N-telopeptídeo do colágeno tipo I (NTx) em pacientes com tumores sólidosNeoplasias ósseasCintilografiaValor preditivo dos testesFosfatase alcalinaColágeno tipo IBone neoplasmsRadionuclide imagingPredictive value of testsAlkaline phosphataseCollagen type ICONTEXT AND OBJECTIVE: Cross-linked N-telopeptides of type I collagen (NTx) increase in concentration in situations in which bone resorption is increased, such as osteoporosis and bone metastasis (BM). We aimed to evaluate the serum concentrations of NTx in a sample of patients with several types of solid tumors. DESIGN AND SETTING: Cross-sectional analytical study with a control group in a tertiary public hospital. METHODS: We performed the quantitative enzyme-linked immunosorbent assay (ELISA) on serum NTx levels in 19 subjects without a history of cancer and 62 patients with various solid tumors who had been referred for a bone scan. Three experienced analysts read all bone scans. RESULTS: The serum NTx levels in patients with cancer and BM, with cancer but without BM and without cancer were 46.77 ± 2.58, 32.85 ± 2.05 and 22.32 ± 2.90 respectively (P < 0.0001). We did not find any significant correlations of serum NTx with age, gender, history of bone pain, tumor type and bone alkaline phosphatase levels. We found a significant correlation between serum NTx and alkaline phosphatase levels (R2 = 0.08; P = 0.022). CONCLUSIONS: Serum NTx levels are significantly higher in patients with solid tumors and bone metastases than they are in patients without bone metastases and in normal controls.CONTEXTO E OBJETIVO: Os N-telopeptídeos do colágeno tipo-I (NTx) elevam-se quando a reabsorção óssea está aumentada, devido a condições como osteoporose e metástase óssea. Sendo assim, temos por objetivo avaliar os níveis séricos de NTx em uma população heterogênea de pacientes com tumores sólidos. TIPO DE ESTUDO E LOCAL: Estudo transversal analítico com grupo controle, realizado em hospital público terciário. MÉTODOS: 19 pacientes sem história de câncer e 62 pacientes com tumores sólidos de vários tipos, encaminhados para estadiamento e investigação dos sintomas esqueléticos, foram avaliados pela técnica de ELISA (Enzyme Linked Immuno Sorbent Assay) quantitativa para a dosagem de NTx. Três especialistas leram todas as imagens ósseas. RESULTADOS: O nível de NTx encontrado em pacientes com câncer e metástase óssea, sem metástase óssea e sem diagnóstico de câncer foi 46,77 ± 2,58, 32,85 ± 2,05 e 22,32 ± 2,90, respectivamente (P < 0,0001). Não encontramos correlação entre o NTx, idade, sexo, história de dor óssea, tipo de tumor e níveis de fosfatase alcalina óssea. Encontramos correlação significativa entre os níveis de NTx e de Fosfatase Alcalina (r² = 0,08, P = 0,022). CONCLUSÃO: O NTx sérico é significativamente mais elevado em pacientes com tumores sólidos e metástases ósseas quando comparado com pacientes sem metástases ósseas e controles normais.São Paulo Medical JournalSão Paulo Medical Journal2009-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicosapm.emnuvens.com.br/spmj/article/view/1843São Paulo Medical Journal; Vol. 127 No. 1 (2009); 19-22São Paulo Medical Journal; v. 127 n. 1 (2009); 19-221806-9460reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APMenghttps://periodicosapm.emnuvens.com.br/spmj/article/view/1843/1737https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessJablonka, FernandoSchindler, FernandaLajolo, Paula PhilbertPinczowski, HélioFonseca, Fernando Luiz AffonsoBarbieri, AntônioMassonetto, Luiz HenriqueKatto, Fábio TadashiGiglio, Auro del2023-09-15T20:12:14Zoai:ojs.diagnosticoetratamento.emnuvens.com.br:article/1843Revistahttp://www.scielo.br/spmjPUBhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2023-09-15T20:12:14São Paulo medical journal (Online) - Associação Paulista de Medicinafalse |
dc.title.none.fl_str_mv |
Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors Dosagem sérica do N-telopeptídeo do colágeno tipo I (NTx) em pacientes com tumores sólidos |
title |
Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors |
spellingShingle |
Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors Jablonka, Fernando Neoplasias ósseas Cintilografia Valor preditivo dos testes Fosfatase alcalina Colágeno tipo I Bone neoplasms Radionuclide imaging Predictive value of tests Alkaline phosphatase Collagen type I |
title_short |
Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors |
title_full |
Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors |
title_fullStr |
Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors |
title_full_unstemmed |
Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors |
title_sort |
Serum cross-linked n-telopeptides of type 1 collagen (NTx) in patients with solid tumors |
author |
Jablonka, Fernando |
author_facet |
Jablonka, Fernando Schindler, Fernanda Lajolo, Paula Philbert Pinczowski, Hélio Fonseca, Fernando Luiz Affonso Barbieri, Antônio Massonetto, Luiz Henrique Katto, Fábio Tadashi Giglio, Auro del |
author_role |
author |
author2 |
Schindler, Fernanda Lajolo, Paula Philbert Pinczowski, Hélio Fonseca, Fernando Luiz Affonso Barbieri, Antônio Massonetto, Luiz Henrique Katto, Fábio Tadashi Giglio, Auro del |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Jablonka, Fernando Schindler, Fernanda Lajolo, Paula Philbert Pinczowski, Hélio Fonseca, Fernando Luiz Affonso Barbieri, Antônio Massonetto, Luiz Henrique Katto, Fábio Tadashi Giglio, Auro del |
dc.subject.por.fl_str_mv |
Neoplasias ósseas Cintilografia Valor preditivo dos testes Fosfatase alcalina Colágeno tipo I Bone neoplasms Radionuclide imaging Predictive value of tests Alkaline phosphatase Collagen type I |
topic |
Neoplasias ósseas Cintilografia Valor preditivo dos testes Fosfatase alcalina Colágeno tipo I Bone neoplasms Radionuclide imaging Predictive value of tests Alkaline phosphatase Collagen type I |
description |
CONTEXT AND OBJECTIVE: Cross-linked N-telopeptides of type I collagen (NTx) increase in concentration in situations in which bone resorption is increased, such as osteoporosis and bone metastasis (BM). We aimed to evaluate the serum concentrations of NTx in a sample of patients with several types of solid tumors. DESIGN AND SETTING: Cross-sectional analytical study with a control group in a tertiary public hospital. METHODS: We performed the quantitative enzyme-linked immunosorbent assay (ELISA) on serum NTx levels in 19 subjects without a history of cancer and 62 patients with various solid tumors who had been referred for a bone scan. Three experienced analysts read all bone scans. RESULTS: The serum NTx levels in patients with cancer and BM, with cancer but without BM and without cancer were 46.77 ± 2.58, 32.85 ± 2.05 and 22.32 ± 2.90 respectively (P < 0.0001). We did not find any significant correlations of serum NTx with age, gender, history of bone pain, tumor type and bone alkaline phosphatase levels. We found a significant correlation between serum NTx and alkaline phosphatase levels (R2 = 0.08; P = 0.022). CONCLUSIONS: Serum NTx levels are significantly higher in patients with solid tumors and bone metastases than they are in patients without bone metastases and in normal controls. |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicosapm.emnuvens.com.br/spmj/article/view/1843 |
url |
https://periodicosapm.emnuvens.com.br/spmj/article/view/1843 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://periodicosapm.emnuvens.com.br/spmj/article/view/1843/1737 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
São Paulo Medical Journal São Paulo Medical Journal |
publisher.none.fl_str_mv |
São Paulo Medical Journal São Paulo Medical Journal |
dc.source.none.fl_str_mv |
São Paulo Medical Journal; Vol. 127 No. 1 (2009); 19-22 São Paulo Medical Journal; v. 127 n. 1 (2009); 19-22 1806-9460 reponame:São Paulo medical journal (Online) instname:Associação Paulista de Medicina instacron:APM |
instname_str |
Associação Paulista de Medicina |
instacron_str |
APM |
institution |
APM |
reponame_str |
São Paulo medical journal (Online) |
collection |
São Paulo medical journal (Online) |
repository.name.fl_str_mv |
São Paulo medical journal (Online) - Associação Paulista de Medicina |
repository.mail.fl_str_mv |
revistas@apm.org.br |
_version_ |
1825135068853567488 |